AB Science SA
PAR:AB

Watchlist Manager
AB Science SA Logo
AB Science SA
PAR:AB
Watchlist
Price: 1.294 EUR -0.46%
Market Cap: 85.6m EUR

Operating Margin
AB Science SA

-509.3%
Current
-1 145%
Average
6%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-509.3%
=
Operating Profit
-5.2m
/
Revenue
1m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
FR
AB Science SA
PAR:AB
77.6m EUR
-509%
US
Eli Lilly and Co
NYSE:LLY
1T USD
44%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
US
Johnson & Johnson
NYSE:JNJ
499.9B USD
27%
CH
Roche Holding AG
SIX:ROG
262.5B CHF
34%
UK
AstraZeneca PLC
LSE:AZN
212B GBP
24%
CH
Novartis AG
SIX:NOVN
211.3B CHF
33%
US
Merck & Co Inc
NYSE:MRK
265.3B USD
38%
DK
Novo Nordisk A/S
CSE:NOVO B
1.5T DKK
42%
IE
Endo International PLC
LSE:0Y5F
212.8B USD
11%
US
Pfizer Inc
NYSE:PFE
142.2B USD
29%
No Stocks Found

AB Science SA
Glance View

Market Cap
77.6m EUR
Industry
Pharmaceuticals

AB Science SA engages in the research, development, and sales of protein kinase inhibitor drugs. The company is headquartered in Paris, Ile-De-France and currently employs 96 full-time employees. The company went IPO on 2010-04-21. The company is engaged in targeted therapies through tyrosine kinase inhibitors for treating diseases with high medical factor in the field of cancer, chronic inflammatory diseases, neurological degenerative disorders and central nervous systems diseases in both human and veterinary medicine. The main focus of the Company is the development of tyrosine kinase inhibitors, for instance Masitinib which is a tyrosine kinase inhibitor used as a veterinary medicine in the treatment of canine mast cell tumors. The firm is present in the United States and Europe. As of December 31, 2013, the Company operated though a subsidiary, AB Science USA LCC, based in the United States.

AB Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-509.3%
=
Operating Profit
-5.2m
/
Revenue
1m
What is the Operating Margin of AB Science SA?

Based on AB Science SA's most recent financial statements, the company has Operating Margin of -509.3%.

Back to Top